首页 > 最新文献

Osteoporosis and sarcopenia最新文献

英文 中文
Teriparatide and etelcalcetide improve bone, fibrosis, and fat parameters in chronic kidney disease model rats. 特立帕肽和依替卡西肽可改善慢性肾病模型大鼠的骨骼、纤维化和脂肪参数。
Pub Date : 2023-12-01 Epub Date: 2023-12-21 DOI: 10.1016/j.afos.2023.11.002
Shun Igarashi, Yuji Kasukawa, Koji Nozaka, Hiroyuki Tsuchie, Kazunobu Abe, Hikaru Saito, Ryo Shoji, Fumihito Kasama, Shuntaro Harata, Kento Okamoto, Keita Oya, Naohisa Miyakoshi

Objectives: Chronic kidney disease (CKD) complicated by secondary hyperparathyroidism (SHPT) is associated with an increased risk of fragility fractures. Etelcalcetide (EC) is a treatment for SHPT that reduces serum parathyroid hormone (PTH) levels. However, the effects of combined treatment with osteoporosis drugs such as teriparatide (TPTD) remain unclear. This study investigates the combined effects of EC and TPTD on bone in CKD model rats.

Methods: The CKD model was established in 8-week-old male Wistar rats by feeding them a 0.75% adenine diet for 4 weeks. At 20 weeks of age, the rats were divided into 4 groups (N = 9-10 in each group): CKD group (vehicle administration), TPTD group (30 μg/kg, 3 times/week), EC group (0.6 mg/kg, daily), and Comb group (TPTD and EC combined). EC was injected for 12 weeks starting at 20 weeks of age, and TPTD was injected for 8 weeks starting at 24 weeks of age. After treatment, the followings were evaluated: bone mineral density, bone strength, biochemical tests, bone and fat histomorphometry, and micro-computed tomography.

Results: In CKD model rats, the combination of EC and TPTD was more effective in increasing cortical bone thickness and bone strength and inhibiting porosity. In addition, the combined treatment decreased bone marrow adiposity and fibrosis, and it increased bone mass and improved bone microstructure in trabecular bone.

Conclusions: With the observed benefits such as improved bone mass, bone strength, structural properties, and bone marrow adiposity, combination therapy may be a potential way to improve bone fragility in CKD.

目的:慢性肾脏病(CKD)并发继发性甲状旁腺功能亢进症(SHPT)会增加脆性骨折的风险。依替卡西肽(EC)是一种治疗 SHPT 的药物,可降低血清甲状旁腺激素(PTH)水平。然而,与特立帕肽(TPTD)等骨质疏松症药物联合治疗的效果仍不明确。本研究探讨了EC和TPTD联合治疗对CKD模型大鼠骨骼的影响:方法:用 0.75% 腺嘌呤饮食喂养 8 周大雄性 Wistar 大鼠 4 周,建立 CKD 模型。20 周龄时,将大鼠分为 4 组(每组 9-10 只):CKD组(给药)、TPTD组(30 μg/kg,每周3次)、EC组(0.6 mg/kg,每天)和Comb组(TPTD和EC联合)。EC 组从 20 周龄开始注射,连续 12 周;TPTD 组从 24 周龄开始注射,连续 8 周。治疗后,对以下项目进行了评估:骨矿物质密度、骨强度、生化测试、骨和脂肪组织形态测量以及显微计算机断层扫描:结果:在 CKD 模型大鼠中,EC 和 TPTD 联合治疗对增加皮质骨厚度和骨强度以及抑制孔隙率更有效。此外,联合治疗还能减少骨髓脂肪和纤维化,增加骨量,改善骨小梁的骨微结构:通过观察骨量、骨强度、结构特性和骨髓脂肪含量的改善等益处,联合疗法可能是改善 CKD 患者骨脆性的一种潜在方法。
{"title":"Teriparatide and etelcalcetide improve bone, fibrosis, and fat parameters in chronic kidney disease model rats.","authors":"Shun Igarashi, Yuji Kasukawa, Koji Nozaka, Hiroyuki Tsuchie, Kazunobu Abe, Hikaru Saito, Ryo Shoji, Fumihito Kasama, Shuntaro Harata, Kento Okamoto, Keita Oya, Naohisa Miyakoshi","doi":"10.1016/j.afos.2023.11.002","DOIUrl":"10.1016/j.afos.2023.11.002","url":null,"abstract":"<p><strong>Objectives: </strong>Chronic kidney disease (CKD) complicated by secondary hyperparathyroidism (SHPT) is associated with an increased risk of fragility fractures. Etelcalcetide (EC) is a treatment for SHPT that reduces serum parathyroid hormone (PTH) levels. However, the effects of combined treatment with osteoporosis drugs such as teriparatide (TPTD) remain unclear. This study investigates the combined effects of EC and TPTD on bone in CKD model rats.</p><p><strong>Methods: </strong>The CKD model was established in 8-week-old male Wistar rats by feeding them a 0.75% adenine diet for 4 weeks. At 20 weeks of age, the rats were divided into 4 groups (N = 9-10 in each group): CKD group (vehicle administration), TPTD group (30 μg/kg, 3 times/week), EC group (0.6 mg/kg, daily), and Comb group (TPTD and EC combined). EC was injected for 12 weeks starting at 20 weeks of age, and TPTD was injected for 8 weeks starting at 24 weeks of age. After treatment, the followings were evaluated: bone mineral density, bone strength, biochemical tests, bone and fat histomorphometry, and micro-computed tomography.</p><p><strong>Results: </strong>In CKD model rats, the combination of EC and TPTD was more effective in increasing cortical bone thickness and bone strength and inhibiting porosity. In addition, the combined treatment decreased bone marrow adiposity and fibrosis, and it increased bone mass and improved bone microstructure in trabecular bone.</p><p><strong>Conclusions: </strong>With the observed benefits such as improved bone mass, bone strength, structural properties, and bone marrow adiposity, combination therapy may be a potential way to improve bone fragility in CKD.</p>","PeriodicalId":94349,"journal":{"name":"Osteoporosis and sarcopenia","volume":"9 4","pages":"121-130"},"PeriodicalIF":0.0,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10874735/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139907270","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Sarcopenia, Frailty, and Intrinsic Capacity 肌肉减少症、虚弱和内在能力
Pub Date : 2021-04-27 DOI: 10.1002/9781119597896.ch10
J. M. Bauer, C. Sieber
{"title":"Sarcopenia, Frailty, and Intrinsic Capacity","authors":"J. M. Bauer, C. Sieber","doi":"10.1002/9781119597896.ch10","DOIUrl":"https://doi.org/10.1002/9781119597896.ch10","url":null,"abstract":"","PeriodicalId":94349,"journal":{"name":"Osteoporosis and sarcopenia","volume":"19 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-04-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"78910433","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
The Role of Mitochondria in Age‐Related Sarcopenia 线粒体在年龄相关性肌肉减少症中的作用
Pub Date : 2021-04-27 DOI: 10.1002/9781119597896.ch3
L. Ferrucci, Marta Zampino, Paul M. Coen, B. Goodpaster
{"title":"The Role of Mitochondria in Age‐Related Sarcopenia","authors":"L. Ferrucci, Marta Zampino, Paul M. Coen, B. Goodpaster","doi":"10.1002/9781119597896.ch3","DOIUrl":"https://doi.org/10.1002/9781119597896.ch3","url":null,"abstract":"","PeriodicalId":94349,"journal":{"name":"Osteoporosis and sarcopenia","volume":"23 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-04-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"83137441","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Nutritional Approaches to Treat Sarcopenia 治疗肌肉减少症的营养方法
Pub Date : 2021-04-27 DOI: 10.1002/9781119597896.ch23
T. Cederholm, J. M. Bauer, A. Cruz-Jentoft
{"title":"Nutritional Approaches to Treat Sarcopenia","authors":"T. Cederholm, J. M. Bauer, A. Cruz-Jentoft","doi":"10.1002/9781119597896.ch23","DOIUrl":"https://doi.org/10.1002/9781119597896.ch23","url":null,"abstract":"","PeriodicalId":94349,"journal":{"name":"Osteoporosis and sarcopenia","volume":"10 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-04-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"87803703","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Deuterated Creatine Dilution to Assess Muscle Mass (D3‐Cr Muscle Mass) in Humans 氘化肌酸稀释评估人类肌肉质量(D3 - Cr肌肉质量)
Pub Date : 2021-04-27 DOI: 10.1002/9781119597896.ch17
P. Cawthon, William J Evans
{"title":"Deuterated Creatine Dilution to Assess Muscle Mass (D3‐Cr Muscle Mass) in Humans","authors":"P. Cawthon, William J Evans","doi":"10.1002/9781119597896.ch17","DOIUrl":"https://doi.org/10.1002/9781119597896.ch17","url":null,"abstract":"","PeriodicalId":94349,"journal":{"name":"Osteoporosis and sarcopenia","volume":"31 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-04-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"84109231","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Beta‐hydroxy‐beta‐methylbutyrate (HMB) and Sarcopenia β -羟基- β -甲基丁酸盐(HMB)与肌肉减少症
Pub Date : 2021-04-27 DOI: 10.1002/9781119597896.ch24
F. Landi, R. Calvani, A. Picca, E. Marzetti
{"title":"Beta‐hydroxy‐beta‐methylbutyrate (HMB) and Sarcopenia","authors":"F. Landi, R. Calvani, A. Picca, E. Marzetti","doi":"10.1002/9781119597896.ch24","DOIUrl":"https://doi.org/10.1002/9781119597896.ch24","url":null,"abstract":"","PeriodicalId":94349,"journal":{"name":"Osteoporosis and sarcopenia","volume":"GE-23 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-04-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"72623135","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Quality of Life and Sarcopenia 生活质量与肌肉减少症
Pub Date : 2021-04-27 DOI: 10.1002/9781119597896.ch21
C. Beaudart, J. Reginster, O. Bruyère, A. Geerinck
{"title":"Quality of Life and Sarcopenia","authors":"C. Beaudart, J. Reginster, O. Bruyère, A. Geerinck","doi":"10.1002/9781119597896.ch21","DOIUrl":"https://doi.org/10.1002/9781119597896.ch21","url":null,"abstract":"","PeriodicalId":94349,"journal":{"name":"Osteoporosis and sarcopenia","volume":"86 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-04-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"77766978","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Adverse Outcomes and Functional Consequences of Sarcopenia 肌少症的不良后果和功能后果
Pub Date : 2021-04-27 DOI: 10.1002/9781119597896.ch7
J. Woo
{"title":"Adverse Outcomes and Functional Consequences of Sarcopenia","authors":"J. Woo","doi":"10.1002/9781119597896.ch7","DOIUrl":"https://doi.org/10.1002/9781119597896.ch7","url":null,"abstract":"","PeriodicalId":94349,"journal":{"name":"Osteoporosis and sarcopenia","volume":"82 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-04-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"73393816","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Sarcopenia and Other Chronic Organ Diseases 肌肉减少症和其他慢性器官疾病
Pub Date : 2021-04-27 DOI: 10.1002/9781119597896.ch14
Hidenori Arai
{"title":"Sarcopenia and Other Chronic Organ Diseases","authors":"Hidenori Arai","doi":"10.1002/9781119597896.ch14","DOIUrl":"https://doi.org/10.1002/9781119597896.ch14","url":null,"abstract":"","PeriodicalId":94349,"journal":{"name":"Osteoporosis and sarcopenia","volume":"9 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-04-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"75829387","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Exercise Interventions to Prevent and Improve Sarcopenia 运动干预预防和改善肌肉减少症
Pub Date : 2021-04-27 DOI: 10.1002/9781119597896.ch22
M. Peterson, J. Serra
{"title":"Exercise Interventions to Prevent and Improve Sarcopenia","authors":"M. Peterson, J. Serra","doi":"10.1002/9781119597896.ch22","DOIUrl":"https://doi.org/10.1002/9781119597896.ch22","url":null,"abstract":"","PeriodicalId":94349,"journal":{"name":"Osteoporosis and sarcopenia","volume":"163 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-04-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"75194989","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
期刊
Osteoporosis and sarcopenia
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1